文献速递疼痛医学

奥哌哌芬类似物STR-324减轻大鼠神经病理性疼痛模型的感觉超敏

The Opiorphin Analog STR-324 Decreases Sensory Hypersensitivity in a Rat Model of Neuropathic Pain.
PubMed 文献 · Anesth Analg · 2018-01-01

本研究在大鼠L5-L6脊神经根结扎诱导的单神经病理性疼痛模型中,连续7天静脉给予STR-324(10或50 µg/h),从第2天到第7天显著减轻机械性异常性疼痛和自发痛相关行为,并减少脊髓c-Fos表达,提示STR-324可能通过抑制内源性伤害性通路发挥镇痛作用,有望成为临床神经病理性疼痛多模式治疗的补充。

要点

  • STR-324连续静脉给药减轻神经病理性疼痛大鼠的机械性异常性疼痛和自发痛行为。
  • STR-324减少脊髓c-Fos表达,提示部分通过抑制内源性伤害性通路起效。
  • STR-324可能成为临床神经病理性疼痛多模式治疗的补充。

核心结论

  • STR-324连续静脉给药可减轻神经病理性疼痛大鼠的机械性异常性疼痛和自发痛相关行为,并减少脊髓c-Fos表达。

研究设计与样本

  • 研究采用L5-L6脊神经根结扎诱导的大鼠单神经病理性疼痛模型,连续7天静脉给予STR-324。

主要发现

  • 与安慰剂组相比,10或50 µg/h STR-324组从第2天到第7天机械性异常性疼痛显著减轻(P < .00001和P < .0011)。
  • 与安慰剂组相比,10或50 µg/h STR-324组从第2天到第7天自发痛相关行为显著减少(P = .028和P = .0049)。
  • STR-324减少了该模型中疼痛诱发的脊髓c-Fos表达。

临床怎么用

  • STR-324可能作为临床神经病理性疼痛多模式治疗的补充药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuropathic pain represents a therapeutic challenge, and treatments with increased efficacy and tolerability still need to be developed. Opiorphin protects endogenous enkephalins from degradation, potentiating enkephalin-dependent analgesia via the activation of opioid pathways. Enkephalins are natural ligands of opioid receptors, with strong affinity for δ-opioid receptors. Expression of functional δ-opioid receptors increases in sensory neurons after peripheral nerve injury in neuropathic pain models. In a postoperative pain model, opiorphin and its stable analog STR-324 have an analgesic potency comparable to that of morphine, but without adverse opioid-related side effects. Consequently, administration of endogenous opiorphin peptides or STR-324 might be effective in managing peripheral neuropathic pain. METHODS: In this study, STR-324 was administered intravenously over the course of 7 days to rats with mononeuropathy induced by L5-L6 spinal nerve root ligation. The rats exhibited mechanical allodynia, thermal hyperalgesia, and spontaneous pain-related behavior throughout the testing period. RESULTS: Here, we report that the continuous administration of STR-324 significantly reduced mechanical allodynia and spontaneous pain-related behavior from day 2 to day 7 in animals that received 10 or 50 µg/h of STR-324 as compared to placebo-treated animals (P < .00001 and P < .0011, respectively, for mechanical allodynia; P = .028 and P = .0049, respectively, for spontaneous pain-related behavior). In addition, STR-324 reduced the pain-evoked expression of spinal c-Fos in this model, demonstrating that it acts at least in part through inhibition of endogenous nociceptive pathways. CONCLUSIONS: These observations suggested that STR-324 may be an effective addition to the multimodal approach for treating clinical neuropathic pain.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Van Elstraete A, Sitbon P, Hamdi L, et al. The Opiorphin Analog STR-324 Decreases Sensory Hypersensitivity in a Rat Model of Neuropathic Pain. Anesth Analg. 2018. PMID: 28806211. doi:10.1213/ANE.0000000000002413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。